Description

5-Amino-1MQ (50mg Vial)

5-Amino-1MQ (50mg) is a research-grade compound supplied as a lyophilised vial for analytical and in-vitro laboratory studies. It is widely examined in scientific research for its involvement in NAD+ pathway modelling, metabolic signalling, and cellular communication studies.
This batch has been tested for purity, confirming suitability for controlled laboratory environments.

---

Key Research Features

• 50mg 5-Amino-1MQ supplied in a sterile lyophilised vial

• Batch tested for purity (internal analytical verification)

• Research-grade handling standards

• Stable compound structure suitable for analytical and in-vitro studies

• Useful for pathway modelling and enzyme-related signalling research

• Secure, tamper-evident laboratory packaging

---

Common Research Areas

5-Amino-1MQ is examined across various laboratory and in-vitro models involving:

• NAD+-related pathway studies

• Metabolic signalling and cellular energy-regulation models

• Enzyme interaction and structural behaviour research

• Biological communication and response mapping

• Compound stability and degradation behaviour under controlled conditions

Researchers use this compound to study enzyme-linked pathways and cellular communication processes. No therapeutic or human application is implied.

---

Research Handling Notes

• Intended strictly for analytical and in-vitro laboratory research

• Batch tested for purity

• No preparation, dosing, or usage instructions are provided

---

Storage & Handling

• Store at 2–8°C in a controlled environment

• Protect from heat, moisture, and direct light

• Keep sealed until laboratory analysis

• Dispose of all materials according to laboratory safety protocols

---

References (For Scientific Literature Context Only)

These publications are provided solely as background scientific literature relevant to 5-Amino-1-methylquinolinium (5-Amino-1MQ) and NNMT-inhibitor research. They do not imply any usage or application of the product.

Liu, J. R., et al. (2021). Roles of Nicotinamide N-Methyltransferase in Obesity and Metabolic Disease. Includes preclinical data where 5-Amino-1MQ modulates NNMT activity and metabolic outcomes.
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC8337113/

Dimét-Wiley, A., et al. (2022). Reduced calorie diet combined with NNMT inhibition (5-Amino-1-methylquinolinium) leads to enhanced metabolic outcomes in preclinical models. Scientific Reports.
URL: https://www.nature.com/articles/s41598-021-03670-5

Awosemo, O., et al. (2021). Development and validation of an LC-MS/MS assay for quantifying 5-Amino-1-methylquinolinium: enabling metabolic and pharmacokinetic tracking.
URL: https://pubmed.ncbi.nlm.nih.gov/34304009/

Jawaria, S., et al. (2025). Metabolic Regulator and Emerging Therapeutic Target: NNMT and its Inhibitors Including 5-Amino-1MQ. Biomolecules.
URL: https://www.mdpi.com/2218-273X/15/9/1281

Sigma-Aldrich (Product Sheet). 5-Amino-1-methylquinolinium (5-Amino-1MQ), ≥98% (HPLC): chemical specification and research-grade listing.
URL: https://www.sigmaaldrich.com/US/en/product/sigma/sml2832

---

Legal & Safety Notice

This product is supplied strictly for in-vitro laboratory research use only. It is not intended for human consumption, therapeutic use, or any in vivo application.

By purchasing this product, the buyer agrees:

• They are a legal adult (18+).

• The compound will be handled only by qualified professionals in controlled laboratory settings.

• Use is restricted to lawful in-vitro research purposes only.

• The buyer assumes full responsibility for proper handling, storage, and laboratory application.

• No warranties are provided beyond suitability for stated research use.

• Phoenix Biolabs accepts no liability for misuse, misapplication, or unauthorised use.

⚠️ For Research Use Only. Not for Human or Veterinary Use.